?? ??? ???? ??? ??? ?? ??? ?? ? ??? ?????:
??, ?? ???? ????? ?? ??? ??? ??? ???? ?? ? ?????.
?? ??: ?? ???? ??? ???? ??? ?? ??? ?? ???? ????. ??? ????? ??? ??? ?? ?? ?? ? ????.
??? ???, ??? ??? ?? ???? ???? ??????? ??? ??? ???? ???? ???? ????? ???????. ??? ??? ??? ???? ???? ?????? ??? ??? ?
???? ??? ??? ?? ??? ?? ??? ??? ??? ??? ??? ?????. ????? ??? ??? ?? ??? ?? ???? ???, ?? ?? ?? ??? ????, ??? ?? ??? ??? ??? ???? ???? ???? ?? ?????.
? ??? ???? ???? ????? ??? ?? ??? ??? ??? ?? ? ?? ???? ? ??? ??? ??? ????. ????? ?? ??? ??? ????, ???? ?? ?????, ???? ??? ??? ???? ??? ? ??? ???. ????
?? ?? ??? ?? ????? ????? ?? ???? ???? ??????? ???? ??? ????? ??? ????? ????? ??? ??? ??? ?? ??? ???? ????? ????.
???? ?? ??? ?????? ????? ??? ????? ???? ??? ????????.
?????????? ??? ???? ??? ??? ????. ???? ?? ?? ??, ?? ??? ???? ?? ?? ????? ???? ??? ?? ?????. ??? ?? ????? ??? ???, ??? ???? ?? ?
The protection and success of Ryoncil ended up evaluated in a multicenter, solitary-arm research in fifty four pediatric examine participants with SR-aGVHD right after going through allo-HSCT. Analyze members obtained intravenous infusion of Ryoncil two times weekly for 4 consecutive weeks, for a co
??????? ?? ????? ??? ?? ??? ?? ??? !! ?? ??? ????? ????? ! ???? ?????????? ??
??? ?? ??? ????? ?? ?? ??? ???? ??? ? ?? ????? ????? ?? ? ??? ????,???? ?? ????? ???? ?? ? ??? ??????. ?? ???? ?? ????? ?????.
???? ?? ??? ??? ??? ???? ? ???? ?? ??? ?? ????? ?? ???? ???? ??? ?? ???, ? ???? ???? ???
Post navigation